display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positivebreast cancer - triple negative
la/mBC - HR positivela/mBC - TNBC - L2 - all populationla/mBC - TNBC - L2 - PDL1 positive
pembrolizumab alone NCT03051659 KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 ... KEYNOTE-119 PD-L1 positive ... KEYNOTE-119 ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons